Entera Bio Ltd. WT EXP 06...

NASDAQ: ENTXW · Real-Time Price · USD
0.00
-0.00 (-100.00%)
At close: Jun 27, 2023, 8:42 PM

Entera Bio WT EXP 062723 Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
181K n/a 134K 571K
Cost of Revenue
172K 56K 101K 373K
Gross Profit
9K -56K 33K 198K
Operating Income
-9.59M -8.89M -13.02M -12.22M
Interest Income
n/a 31K 83K n/a
Pretax Income
9.53M -8.86M -12.93M -12.25M
Net Income
-9.54M -8.89M -13.07M -12.19M
Selling & General & Admin
5.09M 4.43M 7.25M 5.69M
Research & Development
4.5M 4.51M 5.85M 6.77M
Other Expenses
n/a n/a -51K -46K
Operating Expenses
9.59M 8.88M 13.05M 12.41M
Interest Expense
n/a n/a n/a 29K
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
9.77M 8.94M 13.15M 12.79M
Income Tax Expense
14K 29K 137K -59K
Shares Outstanding (Basic)
37.65M 29.01M 28.81M 26.13M
Shares Outstanding (Diluted)
37.65M 29.01M 28.81M 26.13M
EPS (Basic)
-0.25 -0.31 -0.45 -0.47
EPS (Diluted)
-0.25 -0.31 -0.45 -0.47
EBITDA
-9.59M -8.8M -12.87M -12.16M
EBIT
-9.59M -8.86M -13.02M -12.22M
Depreciation & Amortization
n/a 56K 64K 53K